Patent details

EP3313818 Title: METHODS FOR THE TREATMENT OF KAPOSI'S SARCOMA OR KSHV-INDUCED LYMPHOMA USING IMMUNOMODULATORY COMPOUNDS, AND USES OF BIOMARKERS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3313818
WO Application Number:
US2016039245
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP16815375.7
WO Publication Number:
WO2016210262
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
24/06/2016
Grant date:
08/11/2023
EP Publication Date:
02/05/2018
WO Publication Date:
29/12/2016
Claims Translations Received Date:
Claims Translation B1 Received Date:
30/01/2024
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
08/11/2023
EP B1 Publication Date:
08/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
23/06/2036
Lapsed By Expiration Date:
Patent Validated Date:
13/02/2024
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
30/01/2024
 
 

 

Name:
Celgene Corporation
Address:
Route 206 & Province Line Road, 08543, Princeton, NJ, United States of America (US)

From:
08/11/2023
 
 

 

Name:
The U.S.A. as represented by the Secretary, Department of Health and Human Services
Address:
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, Bethesda, MD 20892-7660, United States of America (US)

Historical Applicant/holder

From:
08/11/2023
To:
30/01/2024

 

Name:
Celgene Corporation
Address:
86 Morris Avenue, SUMMIT, NJ 07901, United States of America (US)

Agent

Name:
J.M.H. Duyver lic.
From:
12/02/2024
Address:
Gevers Patents De Kleetlaan 7A, B-1831, Diegem, Belgium (BE)
To:

Inventor

1

Name:
YARCHOAN, Robert
Address:
Bethesda, MD 20817, United States of America (US)

2

Name:
ZELDIS, Jerome
Address:
Princeton, NJ 08540, United States of America (US)

3

Name:
POLIZZOTTO, Mark
Address:
Paddington, New South Wales 2021, Australia (AU)

4

Name:
DAVIS, David
Address:
Bethesda, MD 20817, United States of America (US)

5

Name:
SERETI, Irini
Address:
Washington, DC 20004, United States of America (US)

6

Name:
ULDRICK, Thomas
Address:
Washington, DC 20005, United States of America (US)

7

Name:
WHITBY, Denise
Address:
Frederick, MD 21701, United States of America (US)

8

Name:
KHETANI, Vikram
Address:
Short Hills, NJ 07078, United States of America (US)

Priority

Priority Patent Number:
201562185265 P
Priority Date:
26/06/2015
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
C07D 209/48; A61K 31/404; A61K 45/06; C07D 471/04; C07D 473/34; A61P 35/00;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
07/24
Publication date:
14/02/2024
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
45/23
Publication date:
08/11/2023
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202345
Publication date:
08/11/2023
Description:
Grant (B1)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202400290A
Date Registered:
30/01/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
J.M.H. Duyver lic.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
30/06/2026
Annual Fee Number:
11
Annual Fee Amount:
500 Euro
Last Annual Payment Date:
16/05/2025
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
400 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
12/02/2024 Outgoing Correspondence Letter no formal defects 1 PDF /5/8/0/0/4/0800940085/docs/ep16815375.7_0_591221l271.pdf
30/01/2024 Claims First filed claims 3 PDF /5/8/0/0/4/0800940085/docs/ep16815375.7_1_claims20240130154524777.pdf